Trulieve Cannabis (TRLV)
Vertically integrated medical-cannabis cultivator, manufacturer, and dispensary operator.
$12.45
vs last close−0.02 (−0.16%)
In millions of USD, except per-share figures
| In millions | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 302 | 288 | 293 | 287 | 271 |
| Cost of revenue | 119 | 118 | 118 | 117 | 109 |
| Gross profit | 183 | 170 | 175 | 170 | 162 |
| 131 | 128 | 156 | 135 | 533 | |
| Selling, general & administrative | 101 | 99 | 126 | 105 | 102 |
| Other expenses | 29 | 29 | 29 | 30 | 431 |
| Operating income | 52 | 41 | 19 | 35 | −371 |
| −13 | −12 | −16 | −10 | −13 | |
| Interest income | 4 | 4 | 3 | 3 | 3 |
| Interest expense | 16 | 16 | 15 | 13 | 13 |
| Other non-operating income | −3 | −4 | 2 | −3 | 0 |
| Income before tax | 39 | 29 | 3 | 25 | −383 |
| Income tax expense | 55 | 53 | 48 | 22 | 22 |
| Net income from continuing operations | −16 | −24 | −45 | 3 | −405 |
| Discontinued operations | 0 | −5 | 1 | −1 | −1 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 |
| Net income | −14 | −27 | −43 | 2 | −406 |
| EPS, basic | −$0.07 | −$0.14 | −$0.22 | $0.01 | −$2.10 |
| EPS, diluted | −$0.07 | −$0.14 | −$0.22 | $0.01 | −$2.10 |
| Weighted average shares, basic | 191 | 191 | 192 | 193 | 193 |
| Weighted average shares, diluted | 191 | 191 | 192 | 198 | 193 |
| EBITDA | 98 | 89 | 61 | 82 | −371 |
| Depreciation & amortization | 43 | 43 | 44 | 44 | 0 |
| EBIT | 55 | 45 | 18 | 39 | −371 |